Global and United States Continuous Glucose Monitoring Devices Market Size, Status and Forecast 2021-2027

Continuous glucose monitoring (CGM) devices are the latest advancement in the diabetes monitoring devices market, in which a sensor is linked to the CGM device and is placed on the patient’s skin. The device measures glucose levels in the interstitial fluid at frequent intervals and provides data which is captured via a transmitter to the receiver.

Market Analysis and Insights: Global Continuous Glucose Monitoring Devices Market
The global Continuous Glucose Monitoring Devices market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Continuous Glucose Monitoring Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Continuous Glucose Monitoring Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Continuous Glucose Monitoring Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Continuous Glucose Monitoring Devices market.

Global Continuous Glucose Monitoring Devices Scope and Market Size
Continuous Glucose Monitoring Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Continuous Glucose Monitoring Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sensors
Transmitters & Receivers
Insulin Pumps

Segment by Application
Diabetic Patients
Healthy Individuals

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense

Frequently Asked Questions